OLANZAPINE

Product NDC
50268-617
11-digit product format
502680617
Labeler code
50268
Product ID
50268-617_d5de9d7e-79e3-5f96-e053-2995a90a3079
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
OLANZAPINE
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Labeler
AvPAK
Application
ANDA091415
Marketing category
ANDA
Marketing start
2014-04-23
Marketing end
0000-00-00
Substance
OLANZAPINE
Active strength
15 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50268-617-11EA - Each50268-617d1899701-cab0-4a86-b0a4-806cd742deec12015-05-05
50268-617-13EA - Each50268-61708a2ed86-a61e-4130-8703-48f874691d1812014-11-05

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50268-617OLANZAPINE TABLET, ORALLY DISINTEGRATING [AVPAK]11Legacy NDC20250112_98697cfd-5521-f8a9-af17-555031690b08.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50268-617-135026806171330 BLISTER PACK in 1 BOX (50268-617-13) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (50268-617-11) 30 blister pack2014-04-230000-00-00NoNoCurrent